微信内可能无法直接打开本站。请点右上角 ··· → 在浏览器打开，或复制链接。
STAT+: Novartis gets multiple sclerosis win with BTK inhibitor
RSS 官方收录 · 可信分层展示
关键摘要
Want to stay on top of the science and politics driving biotech today?Sign up to get our biotech newsletter in your inbox.…
- Good morning.
- I know this week probably feels extra long as we approach Labor Day we…
- The need-to-know this morning Alumis said its experimental treatment f…
摘要引擎：抽取
正文提要
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Good morning. I know this week probably feels extra long as we approach Labor Day weekend, but we will get through it together.
The need-to-know this morning
- Alumis said its experimental treatment for lupus failed to achieve the efficacy goals of a mid-stage clinical trial.
Trump strikes more drug pricing deals with biotechs
President Trump yesterday announced that his administration has made deals with nine new companies, joining the 17 that it previously struck agreements with.